Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study
Attalla, W., Abd Elhamidb, T. (2017). Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study. EKB Journal Management System, 7(1), 22-29. doi: 10.21608/ebwhj.2017.3221
Walid Attalla; Tarek Abd Elhamidb. "Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study". EKB Journal Management System, 7, 1, 2017, 22-29. doi: 10.21608/ebwhj.2017.3221
Attalla, W., Abd Elhamidb, T. (2017). 'Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study', EKB Journal Management System, 7(1), pp. 22-29. doi: 10.21608/ebwhj.2017.3221
Attalla, W., Abd Elhamidb, T. Aromatase Inhibitors Versus Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome: a Prospective, Randomized, Double-Blind Study. EKB Journal Management System, 2017; 7(1): 22-29. doi: 10.21608/ebwhj.2017.3221